Current Coverage Archives

Production Milestone Further Positions Modular Medical for U.S. and EU Growth – ( $MODD $LLY $MDT $PODD )

by John F. Heerdink, Jr. August 26, 2025 490Views 0Likes

Modular Medical (NASDAQ: MODD) has announced a series of transformative developments positioning the company at the forefront of diabetes technology innovation. Robust Manufacturing Momentum In August, Modular Medical completed a pivotal production milestone, finalizing over 6,000 MODD1 cartridges and seamlessly transitioning manufacturing…

Serina Therapeutics Gains FDA ‘Green Light’: Seeking to Accelerate Parkinson’s Innovation with POZ Platform – ( $SER $BMY )

by John F. Heerdink, Jr. August 25, 2025 716Views 0Likes

Serina Therapeutics (NYSE American: SER) is rapidly emerging as a compelling force in biotechnology, innovating at the intersection of neuroscience, advanced drug delivery, and capital efficiency—a combination that has resonated with investors and is gaining Wall Street momentum. The latest, game-changing press…

GeoVax Labs Rides Policy Momentum and Clinical Milestones in Multi-Antigen Vaccine Innovation ( $GOVX $IBB $XBI )

by John F. Heerdink, Jr. August 20, 2025 491Views 0Likes

GeoVax Labs (NASDAQ: GOVX), a clinical-stage biotechnology company, has maintained a brisk pace of news in recent months, reflecting dynamic momentum across its vaccine and immunotherapy portfolio. Regulatory Progress and Advances in Vaccine Platforms On the R&D front, GeoVax’s progress is…

Modular Medical Sets New Benchmarks in Insulin Delivery Innovation – ($MODD $TNDM)

by John F. Heerdink, Jr. August 18, 2025 552Views 0Likes

Modular Medical (NASDAQ: MODD) is making a series of dynamic moves in diabetes care, boasting both technological milestones and strategic leadership shifts as it capitalizes on the untapped "almost-pumper" market—adults managing diabetes who remain hesitant to adopt traditional insulin pump therapy. The…

U.S.-Based GeoVax Emerges as Key Monopoly Challenger Amid $2.99B Bavarian Nordic Takeover – ($GOVX $IBB $XBI)

by John F. Heerdink, Jr. July 31, 2025 507Views 0Likes

Bavarian Nordic, a leading Danish vaccine manufacturer best known for its MVA-BN (Modified Vaccinia Ankara–Bavarian Nordic) smallpox and mpox vaccines, recently agreed to a $2.99 billion takeover by private equity firms Permira and Nordic Capital. Shareholders are being offered 233 Danish kroner…

Merck Sets Its Sights on Eyebiotech: Pharma Giant Eyes $1.3 Billion Move Into Vision Care

by John F. Heerdink, Jr. July 11, 2025 406Views 0Likes

Merck (MRK) is setting its sights on a new frontier—your eyes. The pharmaceutical heavyweight is on the verge of acquiring Eyebiotech, an ophthalmology biotech upstart, in a deal valued at a crisp $1.3 billion. If finalized, this move would mark Merck’s debut into the…

From Bitcoin to Ethereum: BitMine’s Bold Treasury Move Draws Wall Street’s Attention ( $BMNR $BTC $ETH )

by John F. Heerdink, Jr. July 1, 2025 438Views 0Likes

BitMine Immersion Technologies (Nasdaq: BMNR), a Las Vegas-based cryptocurrency miner, has dramatically repositioned itself with a bold pivot toward Ethereum, igniting a spectacular surge in its stock price. On June 30, the company announced a $250 million private placement aimed at building…

GeoVax Labs: A Shot in the Arm for Global Health, with a European Twist – ( $GOVX $IBB $XBI )

by John F. Heerdink, Jr. June 18, 2025 476Views 0Likes

In a world where vaccine innovation can sometimes feel like a slow-motion sprint, GeoVax Labs, Inc. (NASDAQ: GOVX) has just received a welcome boost—this time, courtesy of European regulators. The company, known for its nimble approach to tackling some of the world’s…

From Pitch to Palace: The Making of The Knight Sir David Beckham

by John F. Heerdink, Jr. June 13, 2025 470Views 0Likes

Once upon a time in east London, a boy with a mop of hair and a penchant for bending footballs around hapless defenders dreamed of wearing the red of Manchester United and the white of England. That boy, David Beckham, would one…

Mining Meets Modernity At London Tech Week 2025: The Innovation Imperative – ( $RIO )

by John F. Heerdink, Jr. June 10, 2025 426Views 0Likes

Rio Tinto (RIO), the mining titan with a knack for innovation, has set its sights on London Tech Week 2025—and it’s not just there for the canapés. As the only mining company gracing this major technology event, Rio Tinto is making waves…

Current Coverage

Your Guide To Staying Informed In The Markets